by Therapeutic vaccines represent the use of vaccines as a form of treatment for existing illness or disease rather than as a preventive measure. Therapeutic vaccines works by stimulating or restoring the immune system’s ability to fight existing cancer cells or infectious agents. Some key types of therapeutic vaccines includes cancer vaccines, infectious disease vaccines and autoimmune disease vaccines. Cancer vaccines help boost the body’s natural defense system to fight existing cancer cells. Infectious disease vaccines helppatients recover from diseases like HIV/AIDS, hepatitis B, hepatitis C and herpes simplex virus 2. Autoimmune disease vaccines helps reduce symptoms by calming the overactive immune response in autoimmune disorders such as multiple sclerosis and type 1 diabetes.
The global therapeutic vaccines market is estimated to be valued at US$ 3.09 Bn in 2024 and is expected to exhibit a CAGR of 3.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
The increasing demand for targeted disease treatments and preference for personalized medicine over traditional treatment therapies are major market growth drivers. Further, rapid technological advancements resulting in the development of novel vaccine formulations and delivery approaches are also fueling market growth. However, high vaccine development costs and regulatory Issues remain key challenges.
Market Dynamics
The therapeutic vaccines market is expected to be flourished by increasing demand for targeted treatments. One of the major drivers referred from the heading is the increasing demand for targeted disease treatments. Therapeutic vaccines provide targeted treatment by stimulating the body’s own immune system to fight against existing disease causing agents like cancer cells or infectious pathogens. They act as living drugs that harness the power of the immune system with potentially fewer side effects than traditional drug therapies. This drives their increasing adoption over conventional treatment options. Further, as highlighted in the heading, preference for personalized medicine is also fueling the market growth. Therapeutic vaccines allow for a more customized treatment approach tailored to an individual’s specific genetic makeup and disease condition. This personalized treatment approach provides better clinical outcomes and quality of life for patients.
Segment Analysis
The global therapeutic vaccines market can be segmented based on type, indication, end user and geography. Based on type, the market is categorized into cancer vaccines, infectious disease vaccines and autoimmune disease vaccines. Currently, cancer vaccines dominates the market occupying around 30% share owing to rising number of cancer cases globally.
PEST Analysis
Political: Governments across the world are focusing on improving healthcare infrastructure and provide better healthcare facilities to citizens. This has positively impacted investment in vaccine development.
Economic: Growing disposable income, changing lifestyle and awareness have boosted healthcare expenditure worldwide. This increase in spending is driving demand for advanced vaccines.
Social: Rising prevalence of diseases like cancer, HIV and others due to changing environment and lifestyle has increased focus on preventive healthcare. People are more inclined towards vaccination.
Technological: Advancements in biotechnology has enabled development of novel targeted and personalized therapeutic vaccines. This is attracting investments in R&D of innovative vaccines.
Key Takeaways
The Global Therapeutic Vaccines Market Growth is expected to witness high over the forecast period till 2031. Regionally, North America holds the major share of over 35% owing to continuous healthcare infrastructure upgrades, presence of leading players and government support for research.
Regional analysis related content comprises – North America dominates the global market primarily due to rising healthcare spending in the US, high adoption of advanced healthcare technologies and presence of major players. Asia Pacific is expected to witness fastest growth in coming years driven by growing geriatric population, increasing per capita income and expanding healthcare infrastructure in developing countries like India and China.
Key players operating in the therapeutic vaccines market are AMR India Limited, Carmeuse, GLC Minerals LLC, Graymont Limited, Gujarat Mineral Development Corporation Ltd, Imerys, Kerford Limestone, LafargeHolcim, Lhoist Group, Minerals Technologies Inc., Okutama Kogyo Co. Ltd, Omya AG, RSMM Limited, Ryokolime Industry Co. Ltd (Mitsubishi Materials Corporation), SCHAEFER KALK GmbH & Co. KG, The National Lime & Stone Company, and United States Lime & Minerals Inc. Key players focus on new product launches and increasing R&D investment to gain competitive edge in the market.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
